BMO Capital lowered the firm’s price target on Global Medical REIT (GMRE) to $7.50 from $9.50 and keeps a Market Perform rating on the shares. The firm made changes to its models for a number of REITs due to interest rate changes, recent results, and/or discussions with company management.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMRE:
- Global Medical REIT Holds Annual Stockholder Meeting
- Global Medical REIT Reports Steady Q1 2025 Results
- Global Medical REIT Inc’s Mixed Earnings Call Insights
- Global Medical REIT price target lowered to $9.50 from $11 at Alliance Global Partners
- Global Medical REIT price target lowered to $9 from $10 at Baird